Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Lancet (London, England)"
topic_facet:"BNT162 Vaccine"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22BNT162+Vaccine%22&lookfor=%22COVID19%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22BNT162+Vaccine%22&lookfor=%22COVID19%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22BNT162+Vaccine%22&lookfor=%22COVID19%22&type=Subject
PubPharm (24)
1
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters : pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
enthalten in:
Lancet (London, England)
| 2022
von
Agrawal, U.
|
Bedston, S.
|
McCowan, C.
| +24
CommentIn: Lancet. 2022 Oct 15;400(10360):1282-1283. - PMID 36244366
Wird geladen...
2
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy : a retrospective analysis of January-April, 2022
enthalten in:
Lancet (London, England)
| 2022
von
Sacco, C.
|
Del Manso, M.
|
Mateo-Urdiales, A.
| +15
CommentIn: Lancet. 2022 Jul 9;400(10346):74-76. - PMID 35780800
Wird geladen...
3
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease : results of a systematic review and meta-regression
enthalten in:
Lancet (London, England)
| 2022
von
Feikin, D.
|
Higdon, M.
|
Abu-Raddad, L.
| +11
CommentIn: Lancet. 2022 Mar 5;399(10328):887-889. - PMID 35202602
Wird geladen...
4
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine : a retrospective, total population cohort study in Sweden
enthalten in:
Lancet (London, England)
| 2022
von
Nordström, P.
|
Ballin, M.
|
Nordström, A.
CommentIn: Virol J. 2022 Jun 5;19(1):100. - PMID 35659687
Wird geladen...
5
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
enthalten in:
Lancet (London, England)
| 2022
von
Kuhlmann, C.
|
Mayer, C.
|
Claassen, M.
| +8
ErratumIn: Lancet. 2022 Feb 12;399(10325):628. - PMID 35151396
Wird geladen...
6
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001) : a phase 4, non-inferiority, single blind, randomised study
enthalten in:
Lancet (London, England)
| 2022
von
Costa Clemens, S.
|
Weckx, L.
|
Clemens, R.
| +44
CommentIn: Lancet. 2022 Feb 5;399(10324):496-497. - PMID 35074137
Wird geladen...
7
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2) : a single-blind, randomised, phase 2, non-inferiority trial
enthalten in:
Lancet (London, England)
| 2022
von
Stuart, A.
|
Shaw, R.
|
Liu, X.
| +41
CommentIn: Lancet. 2022 Jan 1;399(10319):3-5. - PMID 34883051
Wird geladen...
8
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA : a retrospective cohort study
enthalten in:
Lancet (London, England)
| 2021
von
Tartof, S.
|
Slezak, J.
|
Fischer, H.
| +12
CommentIn: Lancet. 2021 Oct 16;398(10309):1382-1383. - PMID 34656213
Wird geladen...
9
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
enthalten in:
Lancet (London, England)
| 2021
von
Behrens, G.
|
Cossmann, A.
|
Stankov, M.
| +4
CommentOn: Lancet. 2021 Jul 10;398(10295):121-130. - PMID 34181880
Wird geladen...
10
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV) : a single-blind, randomised, non-inferiority trial
enthalten in:
Lancet (London, England)
| 2021
von
Liu, X.
|
Shaw, R.
|
Stuart, A.
| +86
CommentIn: Lancet. 2021 Sep 4;398(10303):819-821. - PMID 34370969
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Lancet (London, England)
Filter aufheben
Thema: BNT162 Vaccine
Medienart
24
Aufsätze
24
E-Artikel
24
E-Ressourcen
Zeitschriftentitel
Lancet (London, England)
Thema
BNT162 Vaccine
24
COVID-19 Vaccines
24
N38TVC63NU
13
Journal Article
11
Letter
11
Research Support, Non-U.S. Gov't
10
B5S3K2V0G8
10
ChAdOx1 nCoV-19
6
Antibodies, Viral
4
RNA, Messenger
4
Randomized Controlled Trial
4
Spike Glycoprotein, Coronavirus
3
2019-nCoV Vaccine mRNA-1273
3
Clinical Trial, Phase II
3
Comment
3
EPK39PL4R4
3
Multicenter Study
2
Antibodies, Neutralizing
2
Immunoglobulin G
2
Observational Study
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2022
17
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
24
Englisch
Haven't found what you're looking for?
Wird geladen...